Kathleen Ott, Esq., ensures that software, medical device and pharmaceutical innovations of clients are well protected in the marketplace. With over a decade of experience, Kathy has evaluated thousands of technology patents, drafted scores of opinions of counsel and guided Fortune 50 and other clients in patent portfolio strategy and management. From the inception of the America Invents Act (AIA), Kathy has represented clients in post-grant proceedings.

(05/22)